Hela SASSI OUICHKA, MD-MSc

Molecular biologist - European Master of science in genetics - European diploma in translational research - Oncogenetic diploma @ASCO

[Hela SASSI OUICHKA, MD-MSc @HelaSassi_MDMSc]

@VivekSubbiah @CD_AACR @AACR @DrChoueiri @weldeiry @Transplant_Doc @doctorpemm @montypal @pashtoonkasi @GIcancerDoc @GlopesMd @Dr_R_Kurzrock @PTarantinoMD Congratulations @VivekSubbiah !!

[Vivek Subbiah, MD @VivekSubbiah]

🚨Another big win for #precisionmedicine
🚨👉🏼Today the FDA approved lirafugratinib for FGFR2‑rearranged cholangiocarcinoma.
⭐️I still remember the first patient in the universe we enrolled on the trial during the peak of the pandemic. Three days in - I called the amazing Ben- the then CMO of @Relay_Tx
“Your drug is working, working too good. We need to work on the right dosing & get it right for patients. I think this baby will graduate someday.” That day is today 🙌🏼 Thankful to all patients who volunteered & the amazing teams that got this to finish line 🙏🏽 !!! @OncoAlert @oncodaily @OncBrothers @ElizSMcKenna @matthewherper @curecc @Aiims1742 @MiteshBorad @AliSchram
👉🏼Link to FDA approval https://t.co/8WTjhiTD98
👉🏼Link to @CD_AACR @AACR bench to bedside publication https://t.co/HeME5d8mRZ

[Toni Choueiri, MD @DrChoueiri]

Nineteen years ago, I joined Dana-Farber—with a little more hair and far fewer meetings!

I’m deeply grateful to the patients who trusted me and to the colleagues, trainees, and teams who made this journey so meaningful. What a privilege—and what a ride!

[Hela SASSI OUICHKA, MD-MSc @HelaSassi_MDMSc]

@tompowles1 @Annals_Oncology @tompowles1 congratulations!!
I am submitting an article this week at @Annals_Oncology

[Hela SASSI OUICHKA, MD-MSc @HelaSassi_MDMSc]

@oncodaily @AlixPanabieres @MayoClinic Bravo @AlixPanabieres ! Je suis admirative de votre parcours 👏👏

[OncoDaily @oncodaily]

Looking Beyond ctDNA to the Next Generation of Liquid Biopsy - Catherine Alix-Panabières (@AlixPanabieres)

https://t.co/4sMmAOhNLG

[OncoDaily @oncodaily]

Pleasure to Collaborate on Mutation-Centric Kinase Repurposing in Rare Cancers - Vivek Subbiah

@VivekSubbiah

https://t.co/sUoSGMkHWD

[Toni Choueiri, MD @DrChoueiri]

In 1948, Sidney Farber and colleagues published his work in @NEJM that helped open the door to modern chemotherapy.

Seeing that history from the same institution — especially after a remarkable #ASCO26 with major plenary contributions and @NEJM papers from @DanaFarber — is humbling.

A powerful reminder that progress in oncology is built across generations: by patients, scientists, clinicians, and teams who keep asking what might be possible.

[Toni Choueiri, MD @DrChoueiri]

Detecting lung cancer 5 years before it happens, in @CellCellPress courtesy of the @CharlesSwanton group.

Astonishing translational work !

https://t.co/EvUmIGVLgs

[OncoDaily @oncodaily]

Hela Sassi Ouichka Shares Findings From the ORIGAMI Study at ASCO26

@GustaveRoussy

https://t.co/TYl66aMjeF

#OncoDaily #ASCO26

[OncoDaily @oncodaily]

Mentorship, Allyship and Sponsorship Shaping the Future of Oncology at ASCO26 - Khalid El Bairi

@elbairikhalid19 @AinhoaMada @kleidamati

https://t.co/hJW6d7eBIT

#OncoDaily #ASCO26

[Gʀᴇɢᴏʀʏ Rɪᴇʟʏ @RielyMD]

Great discussion of KRAS G12D drugs by @KCArbourMD ends by highlighting the @MSK_DeptOfMed KRAS team

[Amer Zeidan عامر زيدان @Dr_AmerZeidan]

True pleasure to meet with many established & rising Arab oncologists, researchers, postdocs, or residents especially from Jordan and Lebanon at the King Hussein Cancer Center @KHCFKHCC health exchange forums in #ASCO2026 @AUB_Lebanon

[Hela SASSI OUICHKA, MD-MSc @HelaSassi_MDMSc]

@PTarantinoMD @DFCI_BreastOnc Impressive work 👏👏👏

[Vivek Subbiah, MD @VivekSubbiah]

🚨⭐️Wow! What a surprise!
⭐️Deeply honored to receive the Indo-American-Cancer-Association Award at @ASCO #ASCO26 for Outstanding Contributions to Drug Development & Pioneering Advances in Clinical Cancer Research 2026
👉This recognition means so much not just as a personal milestone, but as a reflection of the incredible VILLAGE that makes this work possible
🙏 Mentors who shaped MY thinking + collaborators who challenged & inspired me + Patients who trusted me with their care + friends & family who anchored me through it all
🙏Thank you to the IACA @IACAconnect leadership for this honor @DrSwami_Iyer @Santchawla1 Vinay Jain @jamecancerdoc @BrainTumorDoc @SewantiLimaye #PrecisionOncology🙏 #ASCO26 #IACA #DrugDevelopment #CancerResearch @OncoAlert @oncodaily @OpenMedicineHQ

[Hela SASSI OUICHKA, MD-MSc @HelaSassi_MDMSc]

@VivekSubbiah @PGrivasMDPhD @ASCO @Dr_R_Kurzrock @DrChoueiri @neerajaiims @montypal @doctorpemm @GlopesMd @StephenVLiu @weldeiry @NitinJainMD @Daver_Leukemia Congratulations 👏👏👏

[Yüksel Ürün @DrYukselUrun]

This is not just a doubling of survival.
It is the strong signal of a treatment revolution that could reshape pancreatic cancer care, and perhaps many other cancers driven by RAS… @ASCO #asco26 @OncoAlert @OpenMedicineHQ @marklewismd

[Paolo Tarantino @PTarantinoMD]

It was a honor to have the chance to discuss 4 tremendous oral presentations on novel ADCs at #ASCO26.

They tell a clear story: TOPO1 ADCs will soon join the treatment arsenal of SCLC, NEC and GYN cancers.

Many challenges ahead, though. The most key: biomarkers and sequencing.

[Yüksel Ürün @DrYukselUrun]

This is not simply a new pancreatic cancer drug.

Daraxonrasib met all primary and key secondary endpoints in previously treated mPDAC, with median OS 13.2 vs 6.7 months vs chemo.

A hard target is becoming a real therapeutic path.

#ASCO26
@DrChoueiri @TiansterZhang @CathyEngMD @montypal @tompowles1 @brian_rini @cdanicas @GlopesMd @PGrivasMDPhD @nataliagandur @yekeduz_emre @neerajaiims @ASCO @ONCOassist @OpenMedicineHQ @MedwatchKate @scserendipity1 @CParkMD @urotoday @OncLive @crisbergerot @urologysummit @SuyogCancer @Larvol @IMG_Oncologists @marklewismd @KimmieNgMD @DanaFarber

[Harold J. Burstein, MD, PhD, FASCO @DrHBurstein]

For @ASCO aficionados, there have been questions as to how many standing ovations we have seen. The first I saw was adjuvant Herceptin in 2005. ChatGPT generated the list below for me when prompted for ASCO presentations with standing ovations.